KGI in the News
More on the Postdoctoral Professional Masters Degree
February 11, 2011
A follow up to its article on the Postdoctoral Professional Masters, Science Careers spoke with two more PPM graduates who said they found the program "very useful" for their career transitions from the laboratory to the business side of industry.
February 11, 2011
A follow up to its article on the Postdoctoral Professional Masters, Science Careers spoke with two more PPM graduates who said they found the program "very useful" for their career transitions from the laboratory to the business side of industry.
Taken for Granted: Doing Something Different With Your Science
February 4, 2011
Graduates of KGI’s Postdoctoral Professional Masters explain the benefits of attending the program and what they gained in terms of job opportunities, in this story published by Science Careers.
February 4, 2011
Graduates of KGI’s Postdoctoral Professional Masters explain the benefits of attending the program and what they gained in terms of job opportunities, in this story published by Science Careers.
Telltale Chemistry Could Betray ET
January 21, 2011
New criteria for determining whether life exists on another planet has been put forth by KGI Professor Christoph Adami and other researchers, writes the New Scientist.
January 21, 2011
New criteria for determining whether life exists on another planet has been put forth by KGI Professor Christoph Adami and other researchers, writes the New Scientist.
Exhibit Gives KGI Campus a Scientific Heritage
December 29, 2010
KGI's new Science Heritage Center, featured in the Claremont Courier, offers visitors a 70-year history of instruments and devices that helped change the course of science in the 20th century.
December 29, 2010
KGI's new Science Heritage Center, featured in the Claremont Courier, offers visitors a 70-year history of instruments and devices that helped change the course of science in the 20th century.
Donors Rise to Enterprising Challenge
November 16, 2010
One of the most ambitious endeavors in Keck Graduate Institute history has already come to an end—one year early, wrote the Claremont Courier.
November 16, 2010
One of the most ambitious endeavors in Keck Graduate Institute history has already come to an end—one year early, wrote the Claremont Courier.
Benefits of the Orphan Drug Act for Rare Disease Treatments
May 25, 2010
TuftScope, a journal of health, ethics and policy at Tufts University, has published a paper by three KGI students—Boris Gites, Mona Chughtai and Jessica Chang—plus Professor M. Ian Philips, director of KGI’s Center for Rare Disease Therapies, on the positive changes brought about by the Orphan Drug Act to combat rare diseases.
May 25, 2010
TuftScope, a journal of health, ethics and policy at Tufts University, has published a paper by three KGI students—Boris Gites, Mona Chughtai and Jessica Chang—plus Professor M. Ian Philips, director of KGI’s Center for Rare Disease Therapies, on the positive changes brought about by the Orphan Drug Act to combat rare diseases.
Orphan Drug Workshop Discussed
May 14, 2010
The U.S. Food and Drug Administration’s first Orphan Drug Designation Workshop, hosted by KGI’s Center for Rare Disease Therapies, is discussed in the May 2010 edition of Nature Biotechnology journal.
May 14, 2010
The U.S. Food and Drug Administration’s first Orphan Drug Designation Workshop, hosted by KGI’s Center for Rare Disease Therapies, is discussed in the May 2010 edition of Nature Biotechnology journal.
The Postdoctoral Problem: KGI Has an Answer
May 3, 2010
Genome Technology magazine discusses KGI’s new Postdoctoral Professional Masters in Bioscience Management program to demonstrate how this new degree opportunity is helping postdoctoral fellows find a career in today’s life sciences industry.
May 3, 2010
Genome Technology magazine discusses KGI’s new Postdoctoral Professional Masters in Bioscience Management program to demonstrate how this new degree opportunity is helping postdoctoral fellows find a career in today’s life sciences industry.
KGI-hosted FDA Workshop Discussed in Wall Street Journal
March 10, 2010
Staff members at the Food and Drug Administration are doing something unusual. They are leaving Washington to help drug makers take a crucial step in developing drugs for rare diseases.
March 10, 2010
Staff members at the Food and Drug Administration are doing something unusual. They are leaving Washington to help drug makers take a crucial step in developing drugs for rare diseases.
Prof. Jim Cregg’s Research Discussed in Alder Biopharmaceuticals Article
January 4, 2010
Nobody would have guessed the seeds for one of Seattle’s most promising biotech companies were being planted just before Thanksgiving in 2003. That’s when Randy Schatzman had the depressing task of firing all 90 people who worked for him, and closing the doors at Celltech R&D in Bothell, WA.
January 4, 2010
Nobody would have guessed the seeds for one of Seattle’s most promising biotech companies were being planted just before Thanksgiving in 2003. That’s when Randy Schatzman had the depressing task of firing all 90 people who worked for him, and closing the doors at Celltech R&D in Bothell, WA.